Skip to main content
. 2016 Jul;8(7):1497–1503. doi: 10.21037/jtd.2016.05.56

Table 4. Chemotherapy protocol and outcome at re-evaluation.

Chemotherapy protocol and outcome n %
GP 40 23.5
PE 39 22.9
PC 58 34.1
Other 33 19.4
Antibiotic 12 8.3
Disease control at re-evaluation 84 59.6

IQR, interquartile range; GP, gemcitabine-cisplatin; PE, cisplatin-etoposide; PC, paclitaxel-carboplatin.